Infectious disease and cancer

Wisconsin Medical Journal

Volumn 109, Issue 2, 2010, Pages 66-70

  Mazza, Joseph ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ONCOPROTEIN;

ANUS CANCER; B CELL LYMPHOMA; BORRELIA BURGDORFERI; BURKITT LYMPHOMA; CAMPYLOBACTER JEJUNI; CANCER MORTALITY; CARCINOGENESIS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DNA DAMAGE; EPSTEIN BARR VIRUS; GENE MUTATION; GENETIC ANALYSIS; GENITAL TRACT CANCER; GLIOBLASTOMA; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INTESTINE LYMPHOMA; KAPOSI SARCOMA; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE MYELOMA; MURINE LEUKEMIA VIRUS; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; NOTE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PROSTATE CANCER; SIMIAN VIRUS 40; T CELL LEUKEMIA; UTERINE CERVIX CANCER;

COMMUNICABLE DISEASES; HUMANS; NEOPLASMS; RISK FACTORS;

EID: 77952325173     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (27)

1. Zur Hausen H. The search for infectious causes of cancer: where and why. Virology. 2009;392:1-10.
2. Relman DA. The human body as microbial observatory. Nat Genet. 2002;30:131-133.
3. Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci USA. 2004;101:14572-14579.
4. Conley AB, Piriyapongsa J, Jordan IK. Retroviral promoters in the human genome. Bioinformatics. 2008;24:1563-1567.
5. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350:1328-1337.
6. Souza TA, Stollar BD, Sullivan JL, et al. Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc Natl Acad Sci USA. 2005;102:18093-18098.
7. Macsween KF, Crawford DH. Epstein-Barr virus-recent advances. Lancet Infect Dis. 2003;3:131-140.
8. Cohen JI. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases. Semin Hematol. 2003;40:116-123.
9. Fang W, Nath KA, Mackey MF, et al. CD40 inhibits B cell apoptosis by upregulating bcl-xL expression and blocking oxidant accumulation. Am J Physiol. 1997;272:C950-C956.
10. Brousset P, Schlaifer D, Meggetto F, et al. Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease. Blood. 1994;84:2447-2451.
11. Niedobitek G, Kremmer E, Herbst H, et al. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood. 1997;90:1664-1672.
12. Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet. 1991;337:320-322.
13. Su IJ, Chen JY. The role of Epstein-Barr virus in lymphoid malignancies. Crit Rev Oncol Hematol. 1997;26:25-41.
14. Knecht H, Berger C, al-Homsi AS, et al. Epstein-Barr virus oncogenesis. Crit Rev Oncol Hematol. 1997;26:117-135.
15. Kieff ED, Rickinson AB. Epstein Barr Virus and its Replication. In: Knipe DM, Howley PM, eds. Field's Virology. 5th ed. Philadelphia, PA: Lippincott, Williams and Wilkins;2007:1-120.
16. Hawkins EP, Krischer JP, Smith BE, et al. Nasopharyngeal carcinoma in children-a retrospective review and demonstration of Epstein-Barr viral genomes in tumor cell cytoplasm: a report of the Pediatric Oncology Group. Hum Pathol. 1990;21:805-810.
17. Vasef MA, Ferlito A, Weiss LM. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus. Ann Otol Rhinol Laryngol. 1997;106:348-356.
18. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136:1863-1873.
19. Proença-Modena JL, Acrani GO, Brocchi M. Helicobacter pylori: phenotypes, genotypes and virulence genes. Future Microbiol. 2009;4:223-240.
20. Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis. 2008;40:619-626.
21. Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19:1992-1999.
22. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood. 2005;105:2274-2280.
23. Peek RM Jr. Intestinal malignancy and campylobacter jejuni. Gastroenterology. 2004;127:1266-1267.
24. Ferreri AJ, Ernberg I, Copie-Bergman C. Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med. 2009;265:421-438.
25. Du MQ. MALT lymphoma: recent advances in aetiology and molecular genetics. J Clin Exp Hematop. 2007;47:31-42.
26. Shah KV. SV40 and human cancer: a review of recent data. Int J Cancer. 2007;120:215-223.
27. Vilchez RA. Limitations of epidemiological and serologic studies addressing simian virus 40 and non-Hodgkin's lymphoma. Cancer Invest. 2006;24:333-336.